Understanding Patients Views on Deprescribing in Advanced Cancer Care A National Mixed-Method Study

What this Trial Is About

This research aims to understand patients views on deprescribing medications in palliative cancer care, focusing on the challenges of polymedication that can reduce quality of life and increase healthcare costs. The study also investigates factors influencing patients beliefs about deprescribing and evaluates a questionnaire, the rPATD, to measure these perceptions in this specific population. The study consists of two main parts over three years. First, about 25 patients will participate in individual semi-structured interviews over eight months to gather detailed qualitative data. Then, a larger group of 300 patients will complete self-administered questionnaires, including the rPATD and the BMQ, over twelve months to quantify attitudes toward deprescribing. An additional questionnaire on health literacy will also be given during this second phase. Participants will be involved through interviews and questionnaires assessing their perceptions, beliefs, and literacy related to medication use and deprescribing. The researchers will analyze these responses to identify different patient profiles and factors affecting attitudes toward medication reduction. Outcomes focus on patients perceptions at study entry, measured using validated tools, without treatment interventions. The study is observational and aims to improve deprescribing approaches in palliative oncology care.

DEprescribing: Perceptions of PAtients Living With Advanced Cancer